Technology

What is EASY?

EASY is a mammalian coacErvAte-baSed drug deliverY technology platform, designed for the efficient and targeted delivery of nucleic acids, proteins, small molecules, and other therapeutic agents into cells. EASY is engineered from mammalian proteins capable of forming coacervates, which allow for the encapsulation, protection, and intracellular delivery of therapeutic molecules. Unlike traditional delivery methods, EASY employs a non-viral, non-electroporation, and non-liposomal approach, ensuring optimal biocompatibility, high delivery efficiency, and minimal cytotoxicity. By leveraging the unique properties of endogenous coacervate-forming proteins, EASY enables precise intracellular delivery across a wide range of cell types, including primary immune cells, without needs for harsh physical or chemical treatments. Beyond its applications in ex vivo cell engineering, EASY is also designed for in vivo delivery, offering a safe and effective method for systemic or localized therapeutics.

Technology Introduction

How EASY Works

ProteanFect™ Series - The First Product Developed From EASY Platform

Simple

Make The Primary Cell Transfection Simple

ProteanFect enables the successful delivery of mRNA into a wide range of primary cells, including T cells, NK cells, stem cells, neurons, cardiomyocytes, and more

Capacity

High Nucleic Acid Payload Capacity

ProteanFect-formed particles encapsulate hundreds of thousands of nucleic acid molecules, significantly exceeding the payload capacity of lipid nanoparticles

Safety

Superior Cell Compatibility And Safety

ProteanFect achieves higher transfection efficiency and better cell viability in primary cells compared to electroporation, ensuring both safety and optimal performance

Scalable

Easily Scalable For High-Throughput Applications

ProteanFect facilitates the successful transfection of multiple wells with various mRNA molecules, making it ideal for high-throughput applications in large-scale genetic studies

Explore ProteanFect